ALGN logo

Align Technology (ALGN)

Profile

Full Name

Align Technology, Inc.

Ticker Symbol

ALGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

January 30, 2001

Indexes

S&P 500

Website

http://www.aligntech.com

Employees

20945

Key Details

Price

$164.15(-0.89%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.00B(+3.54% YoY)

Annual EPS

$5.62(-3.27% YoY)

PE ratio

29.26

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$164.15
ALGN price is $164.15

30-Day Relative Volume

0.54
ALGN 30-day relative volume is 0.54

Price Performance

Price Most recent change

-0.89%
ALGN price was down -0.89% on Apr 15, 2025

Price YTD change

-21.27%
ALGN price is down -21.27% since January 1st

Price 1-year change

-46.13%
ALGN price is down -46.13% year-on-year

Price 3-year change

-59.95%
ALGN price is down -59.95% over the past 3 years

Price Range

Price All-time high

$737.45
ALGN price is currently -77.74% below its historical high of $737.45

Price 3-year low

$141.74
ALGN price is currently +15.81% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$12.08B
ALGN market capitalization is $12.08 billion

Market cap 3-year change

-62.59%
ALGN market capitalization is down -62.59% over the past 3 years

Market cap All-time high

$57.76B
ALGN market capitalization is currently -79.09% below its historical high of $57.76 billion

Market cap sector rank

94.08%
ALGN market capitalization is higher than 94.08% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-2.24%
ALGN shares outstanding is down -2.24% year-on-year

Shares Outstanding 3-Year Change

-6.61%
ALGN shares outstanding is down -6.61% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.26
ALGN beta is 1.26

200-day SMA

$215.82
ALGN price is currently -23.94% below its 200-day simple moving average

50-day SMA

$177.83
ALGN price is currently -7.69% below its 50-day simple moving average

RSI

48.37
ALGN 14-day relative strength index is 48.37

Volume

0.54
ALGN 30-day relative volume is 0.54

ATR

$9.11
ALGN average true range is $9.11

10-day Historical Volatility

92.25%
ALGN 10-day historical volatility is 92.25%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.00B
ALGN annual revenue is $4.00 billion

Revenue Analysts estimate

$4.09B
ALGN annual revenue is currently -2.26% lower than the consensus analysts' forecast

Revenue 1-year change

+3.54%
ALGN annual revenue is up +3.54% year-on-year

Revenue Sector rank

90.5%
ALGN annual revenue is higher than 90.5% of companies in Healthcare sector

EPS

EPS

$5.62
ALGN annual earnings per share is $5.62

EPS Analysts estimate

$9.95
ALGN annual earnings per share is currently -43.50% lower than the consensus analysts' forecast

EPS 1-year change

-3.27%
ALGN annual earnings per share is down -3.27% year-on-year

EPS Sector rank

96.19%
ALGN annual earnings per share is higher than 96.19% of companies in Healthcare sector

Profit

Gross profit

$2.80B
ALGN annual gross profit is $2.80 billion

Gross margin

70.00%
ALGN annual gross profit margin is 70.00%

Operating profit

$671.76M
ALGN annual operating income is $671.76 million

Operating margin

16.80%
ALGN annual operating profit margin is 16.80%

Net income

$421.36M
ALGN annual net profit is $421.36 million

Net margin

10.54%
ALGN annual net profit margin is 10.54%

Expenses

Total expenses

$3.33B
ALGN annual total expenses is $3.33 billion

Operating expenses

$2.13B
ALGN annual total operating expenses is $2.13 billion

Cost of goods sold

$1.20B
ALGN annual cost of goods sold is $1.20 billion

Selling, general & administrative expenses

$1.76B
ALGN annual SGA is $1.76 billion

Depreciation and amortization

$145.03M
ALGN annual depreciation & amortization is $145.03 million

Interest expense

-
ALGN annual interest expense value is unknown

Income tax

$187.60M
ALGN annual income tax is $187.60 million

EBIT & EBITDA

EBIT

$671.76M
ALGN annual earnings before interest & taxes is $671.76 million

EBITDA

$671.76M
ALGN annual EBITDA is $671.76 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$6.21B
ALGN annual total assets is $6.21 billion

Non current assets

$3.72B
ALGN annual long term assets is $3.72 billion

Current assets

$2.49B
ALGN annual total current assets is $2.49 billion

Cash and cash equivalents

$1.04B
ALGN annual cash & cash equivalents is $1.04 billion

Accounts receivable

$995.68M
ALGN annual accounts receivable is $995.68 million

Inventory

$254.29M
ALGN annual inventory is $254.29 million

Liabilities

Total liabilities

$2.36B
ALGN annual total liabilities is $2.36 billion

Long term liabilities

$324.59M
ALGN annual total long term liabilities is $324.59 million

Current liabilities

$2.04B
ALGN annual total current liabilities is $2.04 billion

Accounts payable

$108.69M
ALGN annual accounts payable is $108.69 million

Debt

Total debt

$119.28M
ALGN annual total debt is $119.28 million

Total debt 1-year change

-5.8%
ALGN annual total debt is down -5.8% year-on-year

Long term debt

$88.21M
ALGN annual long term debt is $88.21 million

Short term debt

$31.06M
ALGN annual short term debt is $31.06 million

Equity & Capital

Shareholders equity

$3.85B
ALGN annual stockholders equity is $3.85 billion

Book value

$3.85B
ALGN annual book value is $3.85 billion

Retained earnings

$2.48B
ALGN annual retained earnings is $2.48 billion

Working capital

$454.41M
ALGN annual working capital is $454.41 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$738.23M
ALGN annual cash flow from operations is $738.23 million

Cash from operations 1-year change

-6.05%
ALGN annual cash flow from operations is down -6.05% year-on-year

Cash from investing

-$254.91M
ALGN annual cash flow from investing activities is -$254.91 million

Cash from investing 1-year change

-30.09%
ALGN annual cash flow from investing activities is down -30.09% year-on-year

Cash from financing

-$355.72M
ALGN annual cash flow from financing activities is -$355.72 million

Cash from financing 1-year change

+40.55%
ALGN annual cash flow from financing activities is up +40.55% year-on-year

CAPEX

CAPEX

$115.58M
ALGN annual capital expenditures is $115.58 million

CAPEX 1-year change

-34.96%
ALGN annual capital expenditures is down -34.96% year-on-year

Free Cash Flow

Free cash flow

$738.23M
ALGN annual free cash flow is $738.23 million

Free cash flow 1-year change

+21.41%
ALGN annual free cash flow is up +21.41% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

70.00%
ALGN annual gross profit margin is 70.00%

Operating margin

16.80%
ALGN annual operating profit margin is 16.80%

Net margin

10.54%
ALGN annual net profit margin is 10.54%

ROA & ROE

ROA

6.85%
ALGN annual return on assets is 6.85%

ROE

11.26%
ALGN annual return on equity is 11.26%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

29.26
ALGN price to earnings ratio is 29.26

PE ratio Sector rank

59.31%
ALGN price to earnings ratio is higher than 59.31% of companies in Healthcare sector

PB Ratio

PB ratio

3.14
ALGN price to book ratio is 3.14

PB ratio Sector rank

73.33%
ALGN price to book ratio is higher than 73.33% of companies in Healthcare sector

PS Ratio

PS ratio

3.02
ALGN price to sales ratio is 3.02

PS ratio Sector rank

52.18%
ALGN price to sales ratio is higher than 52.18% of companies in Healthcare sector

Enterprise value

Enterprise value

$11.16B
ALGN enterprise value is $11.16 billion

Enterprise value Sector rank

92.8%
ALGN enterprise value is higher than 92.8% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

14.33
ALGN EV/EBITDA is 14.33

EV/EBITDA Sector rank

87.47%
ALGN EV/EBITDA is higher than 87.47% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.22
ALGN annual current ratio is 1.22

Quick ratio

1.10
ALGN annual quick ratio is 1.10

Leverage

Debt to equity

0.00
ALGN annual debt to equity ratio is 0.00

Interest coverage ratio

-
ALGN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

9
ALGN piotroski f-score is 9

Altman Z-Score

4.72
ALGN altman z-score is 4.72

Analyst ratings

Recent major analysts updates

Mar 25, 25 Mizuho
Outperform
Mar 18, 25 Piper Sandler
Overweight
Feb 14, 25 Wells Fargo
Overweight
Feb 6, 25 Piper Sandler
Overweight
Feb 6, 25 Needham
Hold
Feb 6, 25 Morgan Stanley
Overweight
Feb 6, 25 Evercore ISI Group
Outperform
Jan 23, 25 Jefferies
Buy
Jan 6, 25 Leerink Partners
Outperform
Dec 13, 24 B of A Securities
Underperform

Institutional Ownership

Similar stocks

ILMN logo
Illumina (ILMN)
GMAB logo
Genmab A/S (GMAB)
ICLR logo
ICON Public Limited (ICLR)
DVA logo
DaVita (DVA)
COR logo
Cencora (COR)
THC logo
Tenet Healthcare (THC)
RVTY logo
Revvity (RVTY)
BMRN logo
BioMarin Pharmaceutical (BMRN)
UHS logo
Universal Health Services (UHS)
  • What is the ticker symbol for Align Technology?
  • Does Align Technology pay dividends?
  • What sector is Align Technology in?
  • What industry is Align Technology in?
  • What country is Align Technology based in?
  • When did Align Technology go public?
  • Is Align Technology in the S&P 500?
  • Is Align Technology in the NASDAQ 100?
  • Is Align Technology in the Dow Jones?
  • When was Align Technology's last earnings report?
  • When does Align Technology report earnings?
  • Should I buy Align Technology stock now?

What is the ticker symbol for Align Technology?

The ticker symbol for Align Technology is NASDAQ:ALGN

Does Align Technology pay dividends?

No, Align Technology does not pay dividends

What sector is Align Technology in?

Align Technology is in the Healthcare sector

What industry is Align Technology in?

Align Technology is in the Medical Instruments & Supplies industry

What country is Align Technology based in?

Align Technology is headquartered in United States

When did Align Technology go public?

Align Technology's initial public offering (IPO) was on January 30, 2001

Is Align Technology in the S&P 500?

Yes, Align Technology is included in the S&P 500 index

Is Align Technology in the NASDAQ 100?

No, Align Technology is not included in the NASDAQ 100 index

Is Align Technology in the Dow Jones?

No, Align Technology is not included in the Dow Jones index

When was Align Technology's last earnings report?

Align Technology's most recent earnings report was on Feb 5, 2025

When does Align Technology report earnings?

The next expected earnings date for Align Technology is Apr 30, 2025

Should I buy Align Technology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page